SRPT Competitors & Alternatives
Compare Sarepta Therapeutics Inc with similar stocks in the same industry
Biotechnology
SRPT
Main Stock$18.56
Tradestie Score
47
Market Cap
$2.02B
Revenue Growth
-0.3%
Analyst Upside
+16.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.33
|
$2.22B | - | 66 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.58
|
$2.21B | - | 70 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.68
|
$2.18B | - | 71 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.83
|
$2.08B | - | 51 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.41
|
$2.01B | - | 58 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.43
|
$1.97B | - | 56 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.48
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$61.56
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$38.86
|
$1.90B | 26.2 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$31.20
|
$1.84B | - | 58 | Compare |
More SRPT Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry